MICROBIOTA COMPOSITION AS A MARKET FOR RESPONSIBILITY FOR CHEMOTHERAPY AND APPLICATION OF MICROBIAL MODULATORS (PRE, PRO OR OR SYNBIOTICS) TO IMPROVE THE EFFECT OF A CANCER TREATMENT

摘要

The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof.